Patents by Inventor Lori Kathleen Klaidman

Lori Kathleen Klaidman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
    Patent number: 5736529
    Abstract: The present invention is directed to methods for reducing the degree of neural degeneration in a mammal due to acute neural trauma by the administration of a NAD-related compound and for kits useful in the method. NAD-related compounds include quinolinic acid; quinolinic acid ribonucleotide; nicotinamide; nicotinic acid; nicotinic acid ribonucleotide; nicotinic acid ribonucleotide, reduced form; nicotinamide ribonucleotide; nicotinamide ribonucleotide, reduced form; nicotinic acid adenine dinucleotide; nicotinic acid adenine dinucleotide, reduced form; nicotinamide adenine dinucleotide (NAD); nicotinamide adenine dinucleotide phosphate (NADP); nicotinamide adenine dinucleotide, reduced form (NADH); and nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 22, 1996
    Date of Patent: April 7, 1998
    Assignee: Neurocal International Inc.
    Inventors: James David Adams, Lori Kathleen Klaidman, Suman Kumar Mukherjee